—

The Ensign Group Inc(ENSG)— 同类公司组

数据截至2026-10-12 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

The Ensign Group Inc的Closelook综合评分为48/100,在同类公司组内排名第7位(共8家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
ENSG The Ensign Group Inc48403443warn20.2%
PACS PACS Group, Inc.54723953ok10.5%
FMS Fresenius Medical Care Corporation50353484info19.9%
RHC.AU Ramsay Health Care Ltd45892252ok3.4%
HALO Halozyme Therapeutics Inc74949448ok4.9%
DXCM DexCom Inc66858035bull9.2%
ONC BeiGene, Ltd.63766230info9%
MEDP Medpace Holdings Inc63857428ok8.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-12

Quick answers

The Ensign Group Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:PACS Group, Inc. (PACS)、Fresenius Medical Care Corporation (FMS)、Ramsay Health Care Ltd (RHC.AU)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)、Medpace Holdings Inc (MEDP)。

ENSG相对同类公司的评分如何?

The Ensign Group Inc的综合评分为48/100,组内排名第7位(共8家),截至2026-10-12;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.